Stock Earnings

Question 1

What are Sumitomo Pharma Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sumitomo Pharma Co Ltd has a total asset of $742,604, Net profit of $23,634

Question 2

What are the key financial ratios for DNPUF?

Accepted Answer

Sumitomo Pharma Co Ltd's Current ratio is 1.29, has a Net margin is 5.92, sales per share of $1,003.88.

Question 3

How is Sumitomo Pharma Co Ltd's revenue broken down by segment or geography?

Accepted Answer

Sumitomo Pharma Co Ltd largest revenue segment is Medical Pharmaceuticals, at a revenue of 398,832,000,000 in the most earnings release.For geography, North America is the primary market for Sumitomo Pharma Co Ltd, at a revenue of 251,814,000,000.

Question 4

Is Sumitomo Pharma Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Sumitomo Pharma Co Ltd has a net profit of $23,634

Question 5

Does Sumitomo Pharma Co Ltd have any liabilities?

Accepted Answer

yes, Sumitomo Pharma Co Ltd has liability of 573,125

Question 6

How many outstanding shares for Sumitomo Pharma Co Ltd?

Accepted Answer

Sumitomo Pharma Co Ltd has a total outstanding shares of 397.28

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	445,205	398,832	314,558	555,544	560,035	515,952
Revenue Growth (YoY)	30%	27%	-43%	-1%	9%	7%
Cost of Revenue	170,811	153,330	126,528	178,494	157,116	137,645
Gross Profit	274,394	245,502	188,030	377,050	402,919	378,307
Selling, General & Admin	167,170	158,295	225,882	283,474	220,620	195,978
Research & Development	41,117	49,865	102,060	131,858	94,903	97,241
Operating Expenses	140,894	227,016	361,778	431,192	342,940	288,288
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	142,819	17,611	-323,114	-47,920	82,961	77,851
Income Tax Expense	-11,904	-6,024	-8,185	48,794	42,361	41,022
Net Income	154,723	23,634	-314,969	-74,512	56,413	56,219
Net Income Growth	-155%	-108%	323%	-231.99%	0%	38%
Shares Outstanding (Diluted)	397.28	397.29	397.29	397.29	397.3	397.29
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	389.44	59.48	-792.79	-187.54	141.99	141.5
EPS Growth	-155%	-108%	323%	-231.99%	0%	38%
Free Cash Flow	22,322	-9,702	-256,488	-1,940	17,745	124,795
Free Cash Flow Per Share	56.18	-24.42	-645.59	-4.88	44.66	314.11
Gross Margin	61.63%	61.55%	59.77%	67.87%	71.94%	73.32%
Operating Margin	29.98%	4.63%	-55.23%	-9.74%	10.7%	17.44%
Profit Margin	34.75%	5.92%	-100.13%	-13.41%	10.07%	10.89%
Free Cash Flow Margin	5.01%	-2.43%	-81.53%	-0.34%	3.16%	24.18%
EBITDA	155,854	38,705	-141,915	-20,038	91,721	106,726
EBITDA Margin	35%	9.7%	-45.11%	-3.6%	16.37%	20.68%
D&A For EBITDA	22,354	20,219	31,833	34,104	31,742	16,707
EBIT	133,500	18,486	-173,748	-54,142	59,979	90,019
EBIT Margin	29.98%	4.63%	-55.23%	-9.74%	10.7%	17.44%
Effective Tax Rate	-8.33%	-34.2%	2.53%	-101.82%	51.06%	52.69%

Sumitomo Pharma Co Ltd (DNPUF) Price

DNPUF Stock Price Chart

DNPUF Income

Follow-Up Questions